Clinical Trial Update: Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

View source ↗

Summary

An ongoing clinical trial evaluating chemoimmunotherapy plus irradiation of residual lesions for extensive-stage small-cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Qingdao Central Hospital | Conditions: Small-cell Lung Cancer, Residual Tumor | Status: RECRUITING